Keywords: genta, updates, ph, iii, genasense, trial, firm

Genta updates on Ph III Genasense trial

Article | 23 May 2005

Print This

US firm Genta has updated results from its Phase III trial of Genasense (oblimersen sodium) Injection in patients with relapsed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in